Biological Dynamics Appoints Kevin Han as New Chief Financial Officer

/

Biological Dynamics announced it has named Kevin Han as its new Chief Financial Officer, bringing a depth of expertise in capital markets and investor relations and a breadth of healthcare industry knowledge. Mr. Han, a veteran life science industry investor, joins Biological Dynamics following an accomplished career in equity research, investment management, and investor relations, specifically focused on the life science tools, diagnostics, and medical technology sectors.

Read More

Biological Dynamics Expands Biomarkers Research Into Alzheimer’s With Funding From Alzheimer’s Drug Discovery Foundation (ADDF)

/

Biological Dynamics receives funding from the Alzheimer’s Drug Discovery Foundation to use its proprietary Verita™ platform to develop a portfolio of assays for detection and quantification of blood-based biomarkers associated with AD and other neurodegenerative conditions.

Read More

Biological Dynamics Initiates New Phase of Next Generation Tuberculosis Test Development

/

Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced a supplemental grant to support efforts to optimize and evaluate the performance of a novel TB test currently in development. The funding is from the Bill & Melinda Gates Foundation.

Read More

Biological Dynamics Enters Collaboration to Advance Access to Novel Diagnostic Solutions to Life Science Customers

/

Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced it has been accepted to Microsoft's One Commercial Partner (OCP) program. The company will use the comprehensive development solutions available to OCP partners to develop and establish a research service delivery model, to provide Microsoft's Life Science partners and customers access to cutting edge molecular diagnostic solutions powered by Biological Dynamics' novel isolation platform.

Read More